Evolution of minimally invasive techniques and surgical outcomes of ALPPS in Italy: a comprehensive trend analysis over 10 years from a national prospective registry
Matteo Serenari(Azienda USL di Bologna), Giacomo Zanus(University of Padua), Jacopo Lenzi, Enrico Gringeri(University of Padua), Fabrizio Di Benedetto(University of Modena and Reggio Emilia), Umberto Cillo(University of Padua), Alessandro Ferrero, Matteo Virdis(University of Parma), Marco Vivarelli(Marche Polytechnic University), Matteo Cescon(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Fabio Forchino, Marco Massani(AULSS 2 Marca Trevigiana), Francesca Ratti(Vita-Salute San Raffaele University), Matteo Zanello(Ospedale Maggiore), Paolo Magistri(University of Modena and Reggio Emilia), Federico Mocchegiani(Marche Polytechnic University), Salvatore Gruttadauria, Nicola Guglielmo(Ospedale di Latisana), M. Colledan(University Hospital Frankfurt), Maurizio Romano(University of Padua), Vincenzo Mazzaferro(Fondazione IRCCS Istituto Nazionale dei Tumori), Stefania Camagni(Ospedale Papa Giovanni XXIII), Raffaele Dalla Valle(University of Parma), Bruno Nardo, Matteo Ravaioli, Elio Jovine(Azienda USL di Bologna), Fabrizio Romano, Andrea Scarinci(Istituti di Ricovero e Cura a Carattere Scientifico), Gian Luca Grazi(Azienda Ospedaliero-Universitaria Careggi), Giuseppe Maria Ettorre(IRCCS San Camillo Hospital), Luca Aldrighetti(Vita-Salute San Raffaele University)
Cited by 15
Related Papers
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
|New England Journal of Medicine|1996|7.1k
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
|The Lancet Oncology|2008|2k
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
|New England Journal of Medicine|2008|1.3k
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
|The Lancet Oncology|2015|1.1k
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
|Journal of Hepatology|2012|821